Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 8 | 2026 | 474 | 2.110 |
Why?
|
| Placenta | 4 | 2025 | 504 | 2.050 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2026 | 3763 | 1.440 |
Why?
|
| Elasticity Imaging Techniques | 5 | 2021 | 161 | 1.240 |
Why?
|
| Skull | 2 | 2018 | 149 | 0.940 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 25 | 0.850 |
Why?
|
| Hepatoblastoma | 5 | 2026 | 204 | 0.840 |
Why?
|
| Nanoparticles | 3 | 2026 | 310 | 0.750 |
Why?
|
| Alzheimer Disease | 4 | 2026 | 878 | 0.730 |
Why?
|
| Brain | 7 | 2026 | 3175 | 0.710 |
Why?
|
| Placenta Accreta | 1 | 2025 | 182 | 0.710 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 65 | 0.630 |
Why?
|
| Amyloid | 1 | 2020 | 72 | 0.620 |
Why?
|
| Movement | 2 | 2018 | 147 | 0.620 |
Why?
|
| Scalp | 1 | 2018 | 59 | 0.520 |
Why?
|
| Liver Neoplasms | 5 | 2026 | 1373 | 0.480 |
Why?
|
| Mice | 13 | 2026 | 18301 | 0.380 |
Why?
|
| Animals | 18 | 2026 | 33912 | 0.340 |
Why?
|
| Pregnancy | 4 | 2025 | 7512 | 0.290 |
Why?
|
| Gadolinium | 2 | 2019 | 110 | 0.280 |
Why?
|
| Liposomes | 2 | 2019 | 201 | 0.280 |
Why?
|
| Biomechanical Phenomena | 3 | 2018 | 279 | 0.270 |
Why?
|
| Nanofibers | 1 | 2026 | 17 | 0.240 |
Why?
|
| Disease Models, Animal | 5 | 2026 | 4697 | 0.240 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.230 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2026 | 69 | 0.230 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2025 | 52 | 0.220 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2026 | 280 | 0.190 |
Why?
|
| Mice, Transgenic | 3 | 2026 | 2326 | 0.180 |
Why?
|
| Cell Line, Tumor | 6 | 2026 | 3748 | 0.180 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 75 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 105 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 2021 | 26 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2026 | 768 | 0.160 |
Why?
|
| Presenilin-1 | 1 | 2020 | 51 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 821 | 0.160 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 84 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 150 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2020 | 358 | 0.150 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 112 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 4738 | 0.150 |
Why?
|
| Phantoms, Imaging | 2 | 2018 | 142 | 0.150 |
Why?
|
| Female | 8 | 2026 | 70963 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2022 | 377 | 0.150 |
Why?
|
| Blood Volume | 1 | 2019 | 73 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 338 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 265 | 0.140 |
Why?
|
| Fluorine | 1 | 2018 | 11 | 0.140 |
Why?
|
| Placentation | 1 | 2019 | 59 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 619 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 394 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 66 | 0.130 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 18 | 0.130 |
Why?
|
| Swine | 2 | 2018 | 1186 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 597 | 0.130 |
Why?
|
| Models, Animal | 1 | 2019 | 450 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2022 | 546 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2020 | 687 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1618 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3819 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 722 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 710 | 0.120 |
Why?
|
| Humans | 13 | 2026 | 131163 | 0.120 |
Why?
|
| White Matter | 1 | 2017 | 219 | 0.110 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 3370 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 587 | 0.100 |
Why?
|
| Vincristine | 2 | 2025 | 187 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2022 | 948 | 0.100 |
Why?
|
| Adult | 2 | 2025 | 31282 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 1011 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2026 | 2465 | 0.070 |
Why?
|
| Apoptosis | 2 | 2025 | 1827 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2026 | 24 | 0.060 |
Why?
|
| Drug Liberation | 1 | 2026 | 45 | 0.060 |
Why?
|
| Polyesters | 1 | 2026 | 37 | 0.060 |
Why?
|
| Aurora Kinase B | 1 | 2026 | 12 | 0.060 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2026 | 33 | 0.060 |
Why?
|
| Indolizines | 1 | 2025 | 10 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2026 | 123 | 0.060 |
Why?
|
| Cyclic N-Oxides | 1 | 2025 | 19 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2026 | 2026 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2025 | 32 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2026 | 149 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2018 | 362 | 0.060 |
Why?
|
| Male | 3 | 2021 | 64957 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2026 | 224 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17753 | 0.050 |
Why?
|
| Cisplatin | 1 | 2026 | 274 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 60 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 826 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 89 | 0.050 |
Why?
|
| Indocyanine Green | 1 | 2023 | 51 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 59 | 0.050 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 58 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 279 | 0.040 |
Why?
|
| Adventitia | 1 | 2022 | 4 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 159 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 246 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2026 | 680 | 0.040 |
Why?
|
| Elasticity | 1 | 2021 | 97 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 757 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 378 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 257 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 44 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 117 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 61 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 74 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 825 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2018 | 52 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2021 | 674 | 0.030 |
Why?
|
| Anisotropy | 1 | 2017 | 117 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1272 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2026 | 2406 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2065 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1796 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3385 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5063 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4686 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21025 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 15110 | 0.010 |
Why?
|